337 related articles for article (PubMed ID: 10607315)
1. Tinea capitis: a current perspective.
Elewski BE
J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):1-20; quiz 21-4. PubMed ID: 10607315
[TBL] [Abstract][Full Text] [Related]
2. Systemic antifungal therapy for tinea capitis in children.
Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C
Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
Gupta AK; Adam P; Dlova N; Lynde CW; Hofstader S; Morar N; Aboobaker J; Summerbell RC
Pediatr Dermatol; 2001; 18(5):433-8. PubMed ID: 11737692
[TBL] [Abstract][Full Text] [Related]
4. Tinea capitis: an overview with emphasis on management.
Gupta AK; Hofstader SL; Adam P; Summerbell RC
Pediatr Dermatol; 1999; 16(3):171-89. PubMed ID: 10383772
[TBL] [Abstract][Full Text] [Related]
5. Tinea capitis.
Gupta AK; Summerbell RC
Med Mycol; 2000 Aug; 38(4):255-87. PubMed ID: 10975696
[TBL] [Abstract][Full Text] [Related]
6. New treatments for tinea capitis.
Chan YC; Friedlander SF
Curr Opin Infect Dis; 2004 Apr; 17(2):97-103. PubMed ID: 15021047
[TBL] [Abstract][Full Text] [Related]
7. Tinea capitis update: a continuing conflict with an old adversary.
Chen BK; Friedlander SF
Curr Opin Pediatr; 2001 Aug; 13(4):331-5. PubMed ID: 11717558
[TBL] [Abstract][Full Text] [Related]
8. Exploring treatment and antifungal resistance in an outbreak of tinea caused by Microsporum audouinii.
Johansen CD; Shen JJR; Astvad KMT; Jemec GBE; Christensen JJ; Saunte DML
Mycoses; 2024 Jul; 67(7):e13760. PubMed ID: 38943042
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic options in the treatment of tinea capitis.
Chan YC; Friedlander SF
Expert Opin Pharmacother; 2004 Feb; 5(2):219-27. PubMed ID: 14996619
[TBL] [Abstract][Full Text] [Related]
10. Continuous increase of Trichophyton tonsurans as a cause of tinea capitis in the urban area of Paris, France: a 5-year-long study.
Gits-Muselli M; Benderdouche M; Hamane S; Mingui A; Feuilhade de Chauvin M; Guigue N; Picat MQ; Bourrat E; Petit A; Bagot M; Alanio A; Bretagne S
Med Mycol; 2017 Jul; 55(5):476-484. PubMed ID: 27744309
[TBL] [Abstract][Full Text] [Related]
11. Microsporum audouinii tinea capitis in a Swiss school: assessment and management of patients and asymptomatic carriers.
Donghi D; Hauser V; Bosshard PP
Med Mycol; 2011 Apr; 49(3):324-8. PubMed ID: 20936914
[TBL] [Abstract][Full Text] [Related]
12. Tinea capitis in children: a systematic review of management.
Gupta AK; Mays RR; Versteeg SG; Piraccini BM; Shear NH; Piguet V; Tosti A; Friedlander SF
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2264-2274. PubMed ID: 29797669
[TBL] [Abstract][Full Text] [Related]
13. Tinea capitis: advances and a needed paradigm shift.
Le TK; Cohen BA
Curr Opin Pediatr; 2021 Aug; 33(4):387-391. PubMed ID: 34226424
[TBL] [Abstract][Full Text] [Related]
14. Systemic antifungal therapy for tinea capitis in children.
González U; Seaton T; Bergus G; Jacobson J; Martínez-Monzón C
Cochrane Database Syst Rev; 2007 Oct; (4):CD004685. PubMed ID: 17943825
[TBL] [Abstract][Full Text] [Related]
15. Tinea Capitis Caused by Microsporum audouinii: Lessons from a Swedish Community Outbreak.
Calander S; Saunte DML; Polesie S
Acta Derm Venereol; 2021 Sep; 101(9):adv00551. PubMed ID: 34436619
[No Abstract] [Full Text] [Related]
16. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials.
Elewski BE; Cáceres HW; DeLeon L; El Shimy S; Hunter JA; Korotkiy N; Rachesky IJ; Sanchez-Bal V; Todd G; Wraith L; Cai B; Tavakkol A; Bakshi R; Nyirady J; Friedlander SF
J Am Acad Dermatol; 2008 Jul; 59(1):41-54. PubMed ID: 18378354
[TBL] [Abstract][Full Text] [Related]
17. [Tinea capitis. Therapeutic options in the post-griseofulvin era].
Möhrenschlager M; Korting HC; Seidl HP; Ring J; Abeck D
Hautarzt; 2002 Dec; 53(12):788-94. PubMed ID: 12444518
[TBL] [Abstract][Full Text] [Related]
18. Inadequate diagnostic testing and systemic antifungal prescribing for tinea capitis in an observational cohort study of 3.9 million children, United States.
Gold JAW; Benedict K; Dulski TM; Lipner SR
J Am Acad Dermatol; 2023 Jul; 89(1):133-135. PubMed ID: 36806646
[No Abstract] [Full Text] [Related]
19. [Tinea capitis: clinical features and therapeutic alternatives].
Messina F; Walker L; Romero MLM; Arechavala AI; Negroni R; Depardo R; Marin E; Santiso GM
Rev Argent Microbiol; 2021; 53(4):309-313. PubMed ID: 33618899
[TBL] [Abstract][Full Text] [Related]
20. Systemic antifungal therapy for tinea capitis in children: An abridged Cochrane Review.
Chen X; Jiang X; Yang M; Bennett C; González U; Lin X; Hua X; Xue S; Zhang M
J Am Acad Dermatol; 2017 Feb; 76(2):368-374. PubMed ID: 27816294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]